SEC Form SC 13G filed

2/16/21 3:39:02 PM ET

$BXRX

Misc Health and Biotechnology Services

Health Care

Get the next $BXRX alert in real time by email

SC 13G 1 baudax13g-021621.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

Baudax Bio, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

07160F107

(CUSIP Number)

December 31, 2020

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
X Rule 13d-1(c)
Rule 13d-1(d)

^* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Capital Partners, L.P.

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	34,160

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	34,160

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	34,160

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Capital Partners 100, L.P.

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	4,554

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	4,554

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	4,554

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Select, L.P.

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	38,132

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	38,132

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	38,132

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Select 100, L.P..

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	5,053

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	5,053

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	5,053

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Capital Investors, Ltd

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	3,691

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	3,691

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	3,691

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	CO

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Select Master Fund, Ltd

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	5,162

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	5,162

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	5,162

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	CO

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Corsair Capital Management, L.P.

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	90,752

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	90,752

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	90,752

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	IA; PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Jay Petschek.

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	90,752

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	90,752

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	90,752

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	IN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Steven Major

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

	(a) [x]
	(b) [ ]

3.	SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION

	United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.	SOLE VOTING POWER

	0

6.	SHARED VOTING POWER

	90,752

7.	SOLE DISPOSITIVE POWER

	0

8.	SHARED DISPOSITIVE POWER

	90,752

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	90,752

10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	Less than 1%

12.	TYPE OF REPORTING PERSON

	IN

This statement was filed with respect to the common stock of Baudax Bio, Inc. (The “Issuer”) beneficially owned by the Reporting Persons identified below as of December 31, 2020.

Item 1.

	(a)	Name of Issuer: Baudax Bio, Inc

	(b)	Address of Issuer’s Principal Executive Offices: 490 Lapp Road Malvern, PA 19355 United States

Item 2.

	(a)	Name of Person Filing The names of the persons filing this statement on Schedule 13G (collectively, the “Reporting Persons”) are: • Corsair Capital Partners, L.P. (“Corsair Capital”) • Corsair Capital Partners 100, L.P. (“Corsair 100”) • Corsair Select L.P. (“Corsair Select”) • Corsair Select 100 L.P. (“Select 100”) • Corsair Capital Investors, Ltd (“Corsair Investors”) • Corsair Select Master Fund, Ltd. (“Select Master”) • Corsair Capital Management, L.P. (“Corsair Management”) • Jay R. Petschek (“Mr. Petschek”) and • Steven Major (“Mr. Major”) Corsair Management acts as the investment manager of Corsair Capital, Corsair 100, Corsair Select, Select 100, Corsair Investors and Select Master. Messrs. Petschek and Major are the controlling persons of Corsair Management.

	(b)	Address of the Principal Office or, if none, residence The principal business address for each of Corsair Capital, Corsair 100, Corsair Select, Select 100, Corsair Management, Mr. Petschek and Mr. Major is 366 Madison Ave, 12^th floor, New York, NY 10017. The principal business address for each of Corsair Investors and Select Master is M&C Corporate Services Ltd, Box 309, George Town, Cayman Islands KY1-1104.

	(c)	Citizenship Each of Corsair Capital, Corsair 100, Corsair Select, Select 100 and Corsair Management is a limited partnership formed under the laws of the State of Delaware. Each of Corsair Investors and Select Master is an exempted company formed under the laws of the Cayman Islands. Each of Mr. Petschek and Mr. Major is a citizen of the United States.

	(d)	Title of Class of Securities Common Stock, $0.01 par value per share (“Common Stock”)

	(e)	CUSIP Number 07160F107

Item 3. If this statement is filed pursuant to 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

Not Applicable.

Item 4. Ownership.


(a)	Amount beneficially owned: Collectively, the Reporting Persons beneficially own 90,752 shares of Common Stock. • Corsair Capital individually owns 34,160 shares of Common Stock. • Corsair 100 individually owns 4,554 shares of Common Stock. • Corsair Select individually owns 38,132 shares of Common Stock. • Select 100 individually owns 5,053 shares of Common Stock. • Corsair Investors individually owns 3,691 shares of Common Stock. • Select Master individually owns 5,162 shares of Common Stock. • Corsair Management, as the investment manager of each of Corsair Capital, Corsair 100, Corsair Select, Select 100, Corsair Investors and Select Master is deemed to beneficially own 90,752 shares of Common Stock.
	• Mr. Petschek, as a controlling person of Corsair Management, is deemed to individually beneficially own 90,752 shares of Common Stock. • Mr. Major, as a controlling person of Corsair Management, is deemed to individually beneficially own 90,752 shares of Common Stock.

(b)	Percent of class: Collectively, the Reporting Persons beneficially own 90,752 shares of Common Stock, representing less than 1% of all of the outstanding shares of Common Stock based on the 26,238,825 outstanding shares of Common Stock as reported on the Issuer’s Form 10-Q filed on November 9, 2020. Corsair Capital’s individual ownership of 34,160 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. Corsair 100’s individual ownership of 4,554 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. Corsair Select’s individual ownership of 38,132 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. Select 100’s individual ownership of 5,053 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. Corsair Investors’ individual ownership of 3,691 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. Select Master’s individual ownership of 5,162 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. Corsair Management’s beneficial ownership of 90,752 shares of Common Stock represents less than 1% of all the outstanding shares of Common Stock. The 90,752 shares of Common Stock deemed to be beneficially owned by Mr. Petschek represents less than 1% of all the outstanding shares of Common Stock. The 90,752 shares of Common Stock deemed to be beneficially owned by Mr. Major represents less than 1% of all the outstanding shares of Common Stock.

(c)	Number of shares as to which the person has:

	(i)	Sole power to vote or to direct the vote shares of Common Stock Not Applicable

	(ii)	Shared power to vote or to direct the vote. Corsair Capital, Corsair Management, Mr. Petschek and Mr. Major have shared power to vote or direct the vote for 34,160 shares of common Stock owned by Corsair Capital. Corsair 100, Corsair Management, Mr. Petschek and Mr. Major have shared power to vote or direct the vote for 4,554 shares of common Stock owned by Corsair 100. Corsair Select, Corsair Management, Mr. Petschek and Mr. Major have shared power to vote or direct the vote for 38,132 shares of common Stock owned by Corsair Select. Select 100, Corsair Management, Mr. Petschek and Mr. Major have shared power to vote or direct the vote for 5,053 shares of common Stock owned by Select 100. Capital Investors, Corsair Management, Mr. Petschek and Mr. Major have shared power to vote or direct the vote for 3,691 shares of common Stock owned by Corsair Investors. Select Master, Corsair Management, Mr. Petschek and Mr. Major have shared power to vote or direct the vote for 5,162 shares of common Stock owned by Select Master.

			(iii)	Sole power to dispose or to direct the disposition of shares of Common Stock Not Applicable

			(iv)	Shared power to dispose or to direct the disposition of: Corsair Capital, Corsair Management, Mr. Petschek and Mr. Major have shared power to dispose or direct the disposition of the 34,160 shares of common Stock owned by Corsair Capital. Corsair 100, Corsair Management, Mr. Petschek and Mr. Major have shared power to dispose or direct the disposition of the 4,554 shares of common Stock owned by Corsair 100. Corsair Select, Corsair Management, Mr. Petschek and Mr. Major have shared power to dispose or direct the disposition of the 38,132 shares of common Stock owned by Corsair Select. Select 100, Corsair Management, Mr. Petschek and Mr. Major have shared power to dispose or direct the disposition of the 5,053 shares of common Stock owned by Select 100. Capital Investors, Corsair Management, Mr. Petschek and Mr. Major have shared power to dispose or direct the disposition of the 3,691 shares of common Stock owned by Corsair Investors. Select Master, Corsair Management, Mr. Petschek and Mr. Major have shared power to dispose or direct the disposition of the 5,162 shares of common Stock owned by Select Master.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

See Exhibits A and B of the Schedule 13G filed with the Securities and Exchange Commission on December 12, 2019.

Item 9. Notice of Dissolution of Group.

Not Applicable.

Item 10. Certification.

By signing below the undersigned certifies that, to the best of its or his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Signature

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated February 16, 2021

CORSAIR CAPITAL PARTNERS, L.P.

By: Corsair Capital Advisors, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

CORSAIR CAPITAL PARTNERS 100, L.P.

By: Corsair Capital Advisors, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

CORSAIR SELECT, L.P.

By: Corsair Select Advisors, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

CORSAIR SELECT 100, L.P.

By: Corsair Select Advisors, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

CORSAIR CAPITAL INVESTORS, LTD.

By: Corsair Capital Management, L.P.,

Attorney-in-Fact

By: Corsair Capital Management GP, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

CORSAIR SELECT MASTER FUND, LTD.

By: Corsair Capital Management, L.P.,

Attorney-in-Fact

By: Corsair Capital Management GP, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

CORSAIR CAPITAL MANAGEMENT, LP.

By: Corsair Capital Management GP, L.L.C.,

General Partner

By: /s/ Jay R. Petschek

Jay R. Petschek, Managing Member

/s/ Jay R. Petschek

Jay R. Petschek

/s/ Steven Major

Steven Major

Get the next $BXRX alert in real time by email

SEC Form SC 13G filed

Chat with this insight

Recent Analyst Ratings for
$BXRX

$BXRX
Leadership Updates

Live Leadership Updates

Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

$BXRX
Press Releases

Fastest customizable press release news feed in the world

Baudax Bio Announces Corporate Update

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

$BXRX
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$BXRX
Large Ownership Changes

This live feed shows all institutional transactions in real time.

$BXRX
SEC Filings

SEC Form 3 filed by new insider Mcandrew Natalie

SEC Form 3: New insider Kim Yong Chan claimed ownership of 202,260 shares

SEC Form 4: Henwood Geraldine bought $3,057 worth of shares (1,200 units at $2.55), increasing direct ownership by 98% to 2,427 units

SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)

SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)

SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)

SEC Form 8-K filed by Baudax Bio Inc.

SEC Form 25-NSE filed by Baudax Bio Inc.

Baudax Bio Inc. filed SEC Form 8-K: Other Events

$BXRX
Financials

Live finance-specific insights

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

Baudax Bio Acquires TeraImmune, Inc.

Baudax Bio Announces Date of Reconvened Annual Meeting

SEC Form SC 13G filed

Chat with this insight

Recent Analyst Ratings for $BXRX

$BXRX Leadership Updates

Live Leadership Updates

Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

$BXRX Press Releases

Fastest customizable press release news feed in the world

Baudax Bio Announces Corporate Update

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

$BXRX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$BXRX Large Ownership Changes

This live feed shows all institutional transactions in real time.

$BXRX SEC Filings

SEC Form 3 filed by new insider Mcandrew Natalie

SEC Form 3: New insider Kim Yong Chan claimed ownership of 202,260 shares

SEC Form 4: Henwood Geraldine bought $3,057 worth of shares (1,200 units at $2.55), increasing direct ownership by 98% to 2,427 units

SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)

SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)

SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)

SEC Form 8-K filed by Baudax Bio Inc.

SEC Form 25-NSE filed by Baudax Bio Inc.

Baudax Bio Inc. filed SEC Form 8-K: Other Events

$BXRX Financials

Live finance-specific insights

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

Baudax Bio Acquires TeraImmune, Inc.

Baudax Bio Announces Date of Reconvened Annual Meeting

Recent Analyst Ratings for
$BXRX

$BXRX
Leadership Updates

$BXRX
Press Releases

$BXRX
Insider Trading

$BXRX
Large Ownership Changes

$BXRX
SEC Filings

$BXRX
Financials